Obexelimab marketing applications for the treatment of IgG4-RD expected to be submitted to the FDA in Q2 2026 and the EMA in H2 2026 based on ...

Rethinking Pain Management in Knee ReplacementTotal knee arthroplasty (TKA) is a common surgical procedure to relieve pain and restore mobility in patients with severe knee arthritis.

Physical exertion combined with deep concentration can severely slow down human reaction times. A recent trial reveals that ...

Tycoon2FA has become a leading phishing-as-a-service (PhaaS) platforms, enabling campaigns that reach over 500,000 organizations monthly, prompting Microsoft’s Digital Crimes Unit (DCU) to work with ...

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall survival; On track for expanded pancreatic cancer ...

Rigel Pharmaceuticals, Inc. ( RIGL) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year ...

A home blood pressure telemonitoring (HBPT) program effectively reduced BP in real-world clinical settings, but its enrollment expenses increased overall costs. The HBPT program reduced BP clinic ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

While Pokémon Pokopia is a massive sandbox that lets you play at your own pace, there are some vital tips to make your ...

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall ...

This useful study supplements previous publications of willed attention by addressing a frontoparietal network that supports internal goal generation. The evidence is solid in analyzing two datasets ...

Trial testing continuous versus single-shot adductor canal block produces a clear winner ...